$24.09
0.17% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US71742Q1067
Symbol
PAHC

Phibro Animal Health Corporation Class A Stock price

$24.09
+7.56 45.74% 1M
+0.70 2.99% 6M
+3.09 14.71% YTD
+5.86 32.14% 1Y
+5.51 29.66% 3Y
-1.09 4.33% 5Y
-11.93 33.12% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.04 0.17%
ISIN
US71742Q1067
Symbol
PAHC
Sector
Industry

Key metrics

Market capitalization $976.45m
Enterprise Value $1.68b
P/E (TTM) P/E ratio 30.83
EV/FCF (TTM) EV/FCF 34.16
EV/Sales (TTM) EV/Sales 1.41
P/S ratio (TTM) P/S ratio 0.82
P/B ratio (TTM) P/B ratio 3.67
Dividend yield 1.99%
Last dividend (FY25) $0.48
Revenue growth (TTM) Revenue growth 19.12%
Revenue (TTM) Revenue $1.19b
EBIT (operating result TTM) EBIT $122.32m
Free Cash Flow (TTM) Free Cash Flow $49.06m
Cash position $70.35m
EPS (TTM) EPS $0.78
P/E forward 26.77
P/S forward 0.81
EV/Sales forward 1.39
Short interest 6.31%
Show more

Is Phibro Animal Health Corporation Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Phibro Animal Health Corporation Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

2x Hold
50%
2x Sell
50%

Analyst Opinions

4 Analysts have issued a Phibro Animal Health Corporation Class A forecast:

Hold
50%
Sell
50%

Financial data from Phibro Animal Health Corporation Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,191 1,191
19% 19%
100%
- Direct Costs 804 804
15% 15%
67%
387 387
28% 28%
33%
- Selling and Administrative Expenses 222 222
15% 15%
19%
- Research and Development Expense - -
-
-
165 165
51% 51%
14%
- Depreciation and Amortization 42 42
19% 19%
4%
EBIT (Operating Income) EBIT 122 122
66% 66%
10%
Net Profit 32 32
142% 142%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Phibro Animal Health Corporation Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Phibro Animal Health Corporation Class A Stock News

Neutral
Seeking Alpha
10 days ago
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q3 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Hello and thank you for sta...
Neutral
Business Wire
13 days ago
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an incr...
Neutral
Business Wire
14 days ago
TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leadin...
More Phibro Animal Health Corporation Class A News

Company Profile

Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Head office United States
CEO Jack Bendheim
Employees 1,940
Founded 1946
Website www.pahc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today